Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma [Phase 2]
Phase 2 trial evaluating bendamustine, prednisone, and Velcade for first-line treatment of symptomatic multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus [Phase 2]
Phase II trial of systemic Edmonston strain measles virus (oncolytic virotherapy) for multiple myeloma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: A Phase 2 Trial of Filanesib in Relapsed/Refractory Multiple Myeloma (AfFIRM) [Phase 2]
Phase 2 trial update for filanesib in relapsed/refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating low-dose azacitidine, lenalidomide, and low-dose dexamethasone in relapsed or refractory multiple myeloma has com…
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Clinical and Sociodemographic Characterization of Multiple Myeloma Participants With Symptomatic Relapse and/or Refractory Disease in Spain (CharisMMa Study)
Clinical trial update describing characterization of multiple myeloma participants with symptomatic relapse or refractory disease in Spain (…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma [Phase 1]
Phase 1 trial investigating plitidepsin in combination with bortezomib and dexamethasone in patients with multiple myeloma has completed wit…
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma [Phase 3]
Phase 3 trial evaluating thalidomide and prednisone after autologous stem cell transplantation in multiple myeloma completed with posted res…
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: Tandem Autologous Stem Cell Transplantation in Treating Patients With Primary Systemic (AL) Amyloidosis [Phase 2]
Phase 2 trial update evaluating tandem autologous stem cell transplantation in patients with primary systemic (AL) amyloidosis.
-
CLINICAL_TRIALS trial_result · 2020-09-17Clinical Trial Update: Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma [Phase 2]
Phase 2 trial evaluating a bortezomib, thalidomide, and dexamethasone regimen after autologous stem cell transplant in stage I-III multiple …
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma [Phase 2]
Phase 2 study of filanesib (ARRY-520) in combination with carfilzomib in advanced multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2020-09-11Clinical Trial Update: Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma. [Phase 3]
A Phase 3 trial of carfilzomib, daratumumab, and dexamethasone in patients with relapsed and/or refractory multiple myeloma has completed wi…
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases [Phase 2]
Phase 2 trial evaluating myeloablative umbilical cord blood transplantation in various hematological diseases has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2020-09-07Clinical Trial Update: Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM) [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and tolerability of BION-1301 in adults with relapsed or refractory multiple myeloma has terminated with re…
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: A Study for Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple Myeloma [Phase 2]
Phase 2 trial assessing treatment in patients with Waldenstrom's Macroglobulinemia or Multiple Myeloma; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-01Clinical Trial Update: Combination Bortezomib-containing Regimens in Newly Diagnosed Patients With t (4; 14) Positive Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating combination bortezomib-containing regimens in newly diagnosed t(4;14) positive multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2020-09-01Clinical Trial Update: Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating carfilzomib and melphalan as conditioning therapy before stem cell transplant in multiple myeloma patien…
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 study assessing safety and efficacy of single weekly bortezomib in newly diagnosed multiple myeloma has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 trial evaluating a conditioning regimen of busulfan, melphalan, and bortezomib before first-line stem cell transplant in multiple my…
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: Selinexor Treatment of Refractory Myeloma [Phase 2]
Phase 2 clinical trial update for selinexor in refractory multiple myeloma has completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT [Phase 1, Phase 2]
Clinical trial update on an IL-15 super agonist ALT-803 for relapse of hematologic malignancies after allogeneic stem cell transplant, compl…
-
CLINICAL_TRIALS trial_result · 2020-08-06Clinical Trial Update: A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide. [Phase 2]
Phase 2 trial updates for elotuzumab combinations in relapsed/refractory multiple myeloma, including combinations with pomalidomide/dexameth…
-
CLINICAL_TRIALS trial_result · 2020-07-30Clinical Trial Update: Study Association of Lenalidomide, Ixazomib, Dexamethasone and Daratumumab in Newly Diagnosed Standard Risk Multiple Myeloma [Phase 2]
Phase 2 clinical trial investigating a combination of lenalidomide, ixazomib, dexamethasone, and daratumumab in newly diagnosed standard-ris…
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma [Phase 3]
Phase 3 trial comparing subcutaneous versus intravenous daratumumab in relapsed or refractory multiple myeloma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Study of the Efficacy and Safety of RsqVD Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of RsqVD combination therapy in newly diagnosed multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: Phase 1b/2, Multicenter, Open-label Study of Oprozomib and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma [Phase 1, Phase 2]
A multicenter open-label Phase 1b/2 trial of oprozomib with dexamethasone in relapsed/refractory multiple myeloma has been terminated with r…